Clinical Effects of Excessive Insulin Injection
Injecting an excessive amount of insulin causes hypoglycemia, which can progress to severe neuroglycopenia with coma, seizures, neurologic impairment, and potentially death if not promptly treated. 1
Immediate Clinical Manifestations
The primary consequence of insulin overdose is hypoglycemia resulting from insulin excess relative to glucose availability 1. The severity and duration depend on:
- Dose administered: Cases range from 20 units to 16,000 units in documented overdoses 2, 3
- Type of insulin: Long-acting insulins (glargine, detemir) cause prolonged hypoglycemia lasting 48-96 hours or longer 4, while rapid-acting insulins have shorter but more acute effects
- Route of administration: IV administration of subcutaneous insulin doses causes severe hypoglycemia due to immediate systemic absorption 1
Neurologic Effects
Severe hypoglycemia can cause profound neuroglycopenia leading to:
- Altered mental status and decreased Glasgow Coma Scale
- Loss of consciousness
- Seizures
- Permanent neurologic damage if treatment is delayed 2, 5
- Death (mortality rate 2.7% in overdoses, with poorest prognosis in patients with GCS <12 at 12 hours post-overdose) 5
The neurogenic warning symptoms (tremor, palpitations, sweating) may be blunted or absent, particularly in patients with long-standing diabetes, autonomic neuropathy, or those on beta-blockers 6, 1. This can result in severe hypoglycemia occurring before the patient recognizes symptoms 6.
Metabolic and Systemic Complications
Beyond hypoglycemia, excessive insulin causes:
Electrolyte Disturbances
- Hypokalemia (insulin drives potassium intracellularly)
- Hypophosphatemia
- Hyponatremia 3
Hepatic Effects
Cardiovascular/Pulmonary
- Adult respiratory distress syndrome (ARDS) has been documented in insulin overdose cases 2
- Sodium retention and edema 1
Duration of Effect
The hypoglycemic effect can persist for days, particularly with long-acting insulin formulations 2, 4. The duration correlates with:
- Insulin dose and type
- Slow release from the subcutaneous injection depot 2
- For long-acting analogues like glargine U300, bimodal or polyphasic insulin peaks may occur, extending the risk period 7
Treatment Requirements
Mild hypoglycemia can be treated with oral glucose, but severe cases require:
- Intramuscular/subcutaneous glucagon for immediate rescue 1
- Concentrated intravenous glucose (10-50% dextrose solutions) 1, 3, 5
- Continuous glucose infusion often for 48-96 hours or longer 3, 5, 4
- Frequent blood glucose monitoring (every 1-2 hours initially) 5
- Glucose requirements are highest in the first 24 hours 2
Critical Pitfall
After apparent clinical recovery, continued observation and additional carbohydrate intake are necessary to prevent recurrence of hypoglycemia 1. This is especially important with long-acting insulins where the depot effect continues for days 4.
Advanced Interventions
In extreme cases with massive long-acting insulin overdose, surgical excision of the injection site has been successfully used to remove the insulin depot, even days after injection 4.
Monitoring Parameters
Beyond glucose, monitor:
- Serum potassium, phosphate, sodium
- Liver enzymes
- Mental status and neurologic function
- Blood insulin levels (can predict when overdose effects will cease) 4, 7
The key to preventing mortality and permanent neurologic sequelae is rapid recognition and aggressive, prolonged glucose replacement therapy 2, 5.